Quick Links

Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors

Published: 19 Nov 2013

Regado Biosciences, Inc. (RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced the appointment of Pierre Legault (MBA'89), MBA, CA, CPA, to its Board of Directors, where he will serve as Chairman of the audit committee.

... In addition, Mr. Legault has served on several public, private and nonprofit company boards and audit committees, including Forest Laboratories, Inc., on which he serves currently as audit committee Chairman. Prior board positions include OSI Investment Holdings GMBH (Chairman), Cyclacel Pharmaceutical Inc., PJC Inc., as well as other private boards. Mr. Legault studied at the Harvard Business School in an executive masters program and he received his MBA from McGill University and his BAA from University of Montreal (HEC). He also holds CA and CPA degrees.

Read full article: Yahoo! Finance, November 18, 2013

Source Site: /desautels

Desautels Faculty of Management on Social Media

Desautels Faculty of Management at McGill on FacebookDesautels Faculty of Management at McGill on TwitterDesautels Faculty of Management at McGill, BCom Program on LinkedInDesautels Faculty of Management at McGill, MBA Program on LinkedInDesautels Faculty of Management at McGill on YouTube

Research at Desautels Faculty of Management

Accounting at Desautels Faculty of ManagementFinance at Desautels Faculty of ManagementInformation Systems at Desautels Faculty of ManagementMarketing at Desautels Faculty of ManagementOperations Management at Desautels Faculty of ManagementOrganizational Behaviour at Desautels Faculty of ManagementStrategy and Organization at Desautels Faculty of ManagementHealth Care at Desautels Faculty of Management